Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2022 Jun 29

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

Letter to the Editor   Free accessfree

Minerva Medica 2022 Jun 29

DOI: 10.23736/S0026-4806.22.08257-X

Copyright © 2022 EDIZIONI MINERVA MEDICA

language: English

A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular haemorrhage

Lingying YE 1, Ronghan WU 2, Jin LI 1, Zhixiang HU 2

1 Cataract department, Eye Hospital of Wenzhou Medical University, Wenzhou, China; 2 Fundus Disease Center, Eye Hospital of Wenzhou Medical University, Wenzhou, China


PDF


top of page